Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Apple
AAPL
|
+$564M |
| 3 |
Amazon
AMZN
|
+$486M |
| 4 |
Meta Platforms (Facebook)
META
|
+$331M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$1.88B |
| 2 |
Alibaba
BABA
|
+$1.21B |
| 3 |
Home Depot
HD
|
+$320M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$274M |
| 5 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.98% |
| 2 | Financials | 13.87% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 11.81% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Tecnoglass Holdings Inc.
TGLS
$2B
| $4.05M | ﹤0.01% |
189,376
+14,428
| +8% | +$239K |
|
3027
Centrus Energy
LEU
$3.55B
| $4.04M | ﹤0.01% |
159,256
+91,243
| +134% | +$2.18M |
|
3028
Solid Biosciences
SLDB
$788M
| $4.04M | ﹤0.01% |
73,602
+37,392
| +103% | +$2.47M |
|
|
PSTL
3029
Postal Realty Trust
PSTL
$701M
| $4.04M | ﹤0.01% |
221,367
+121,395
| +121% | +$2.36M |
|
3030
4D Molecular Therapeutics
FDMT
$522M
| $4.03M | ﹤0.01% |
167,434
+21,136
| +14% | +$647K |
|
|
ITIC
3031
Investors Title Co
ITIC
$556M
| $4.02M | ﹤0.01% |
23,039
+1,743
| +8% | +$303K |
|
3032
Mustang Bio
MBIO
$4.26M
| $4.01M | ﹤0.01% |
1,612
+423
| +36% | +$1.04M |
|
|
ONIT
3033
Onity Group
ONIT
$310M
| $4.01M | ﹤0.01% |
129,401
+65,000
| +101% | +$1.98M |
|
3034
Daktronics
DAKT
$968M
| $4M | ﹤0.01% |
607,294
+3,936
| +0.7% | +$25.7K |
|
|
KIN
3035
DELISTED
Kindred Biosciences, Inc.
KIN
| $4M | ﹤0.01% |
435,705
-262,494
| -38% | -$1.53M |
|
|
FTSI
3036
DELISTED
FTS International, Inc. Common Stock
FTSI
| $3.99M | ﹤0.01% |
141,148
+71,929
| +104% | +$1.87M |
|
3037
KALA BIO
KALA
$15.3M
| $3.99M | ﹤0.01% |
302
+29
| +11% | +$456K |
|
3038
Alpha Metallurgical Resources
AMR
$1.7B
| $3.98M | ﹤0.01% |
155,247
+9,484
| +7% | +$163K |
|
3039
ThredUp
TDUP
$788M
| $3.97M | ﹤0.01% |
+136,574
| New | +$2.95M |
|
|
AFIB
3040
DELISTED
Acutus Medical Inc
AFIB
| $3.96M | ﹤0.01% |
233,058
+12,109
| +5% | +$177K |
|
3041
Pulse Biosciences
PLSE
$2.53B
| $3.95M | ﹤0.01% |
241,115
+5,222
| +2% | +$99.4K |
|
|
RYZ
3042
Ryerson Holding Corp
RYZ
$1.44B
| $3.95M | ﹤0.01% |
270,791
+10,347
| +4% | +$163K |
|
3043
UBS Group
UBS
$173B
| $3.95M | ﹤0.01% |
257,527
-19,307
| -7% | -$305K |
|
3044
Kinetik
KNTK
$3.67B
| $3.94M | ﹤0.01% |
116,788
+54,986
| +89% | +$1.74M |
|
3045
Fiverr
FVRR
$341M
| $3.94M | ﹤0.01% |
16,237
+12,273
| +310% | +$2.55M |
|
3046
Atlanticus Holdings
ATLC
$1.64B
| $3.93M | ﹤0.01% |
98,925
+2,119
| +2% | +$74.2K |
|
3047
SkyWater Technology
SKYT
| $3.92M | ﹤0.01% |
+136,758
| New | +$3.38M |
|
3048
Rimini Street
RMNI
$451M
| $3.9M | ﹤0.01% |
633,305
+229,231
| +57% | +$1.68M |
|
3049
Arbutus Biopharma
ABUS
$867M
| $3.9M | ﹤0.01% |
1,286,658
+752,076
| +141% | +$2.33M |
|
3050
Red River Bancshares
RRBI
$655M
| $3.88M | ﹤0.01% |
76,771
+1,963
| +3% | +$107K |
|
Similar funds
Geode Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
- Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
- Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
- Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
- Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
- Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.
Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.